Retatrutide/">Retatrutide/">Retatrutide/">Retatrutide/">Retatrutide/">Retatrutide/">Retatrutide/">Retatrutide is a synthetic peptide compound with significant hypoglycemic effects, primarily used in type 2 diabetes research. This glucose-dependent insulinotropic peptide demonstrates multiple pharmacological actions including stimulation of insulin secretion and inhibition of glucagon release.
The white freeze-dried powder formulation maintains excellent stability when stored in cool, dry conditions. Each vial contains precisely measured 10mg of high purity Retatrutide (≥99%), ensuring consistent results for research applications.
Research studies have demonstrated Retatrutide's ability to delay gastric emptying, reduce both fasting and postprandial blood glucose concentrations, decrease food intake, and promote weight reduction in experimental models of type 2 diabetes.
This pharmaceutical intermediate is supplied in sterile vials (10mg/vial) with 10 vials per box. The product undergoes rigorous quality control testing including HPLC analysis to verify purity and sterility testing to ensure research-grade quality.
For research use only. Not for human consumption. This product should only be handled by qualified researchers in controlled laboratory settings.